4.32

1.41% 0.06

Pre-mercato: 4.32

Outset Medical Inc (OM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché OM Giù? Forum Previsione

Precedente Chiudi:

$4.26

Aprire:

$4.3

Volume 24 ore:

103.43K

Relative Volume:

0.59

Capitalizzazione di mercato:

$80.08M

Reddito:

$117.59M

Utile/perdita netta:

$-74.85M

Rapporto P/E:

-1.0347

EPS:

-4.175

Flusso di cassa netto:

$-34.25M

1 W Prestazione:

+19.01%

1M Prestazione:

-4.42%

6M Prestazione:

+0.70%

1 anno Prestazione:

-76.61%

Intervallo 1D:

$4.11

$4.4499

Intervallo di 1 settimana:

$3.574

$4.4499

Portata 52W:

$3.00

$21.98

Outset Medical Inc Stock (OM) Company Profile

Nome

Outset Medical Inc

Settore

Healthcare (1106)

Industria

Medical Devices (143)

Telefono

669-231-8200

Indirizzo

3052 ORCHARD DRIVE, SAN JOSE

Dipendente

310

Cinguettio

Prossima data di guadagno

2026-05-07

Ultimi documenti SEC

OM's Discussions on Twitter

Compare OM vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OM Outset Medical Inc	4.32	78.97M	117.59M	-74.85M	-34.25M	-4.175
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Outset Medical Inc Stock (OM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-08	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2024-06-21	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2024-04-08	Iniziato	BTIG Research	Buy
2024-04-05	Aggiornamento	CL King	Neutral → Buy
2024-01-12	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2023-10-13	Downgrade	BofA Securities	Buy → Underperform
2023-08-17	Iniziato	CL King	Neutral
2022-11-11	Iniziato	RBC Capital Mkts	Outperform
2022-07-14	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-03-02	Ripresa	BofA Securities	Buy
2022-02-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-08-18	Iniziato	Cowen	Outperform
2021-04-19	Iniziato	Wells Fargo	Overweight
2020-12-16	Iniziato	Oppenheimer	Perform
2020-10-12	Iniziato	Barclays	Overweight
2020-10-12	Iniziato	BofA Securities	Buy
2020-10-12	Iniziato	Goldman	Buy
2020-10-12	Iniziato	Morgan Stanley	Equal-Weight
2020-10-12	Iniziato	SVB Leerink	Mkt Perform
2020-10-12	Iniziato	Stifel	Buy

Mostra tutto

Outset Medical Inc Borsa (OM) Ultime notizie

May 21, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 21, 2026

May 20, 2026

Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN

May 20, 2026

Outset Medical: General counsel Brottem sells $9,760 in shares - Investing.com India

May 20, 2026

Outset Medical CEO Leslie Trigg sells $12,746 in OM shares - Investing.com India

May 20, 2026

May 19, 2026

Outset Medical EVP Marc Nash sells $5,853 in common stock - Investing.com India

May 19, 2026

Outset Medical EVP Marc Nash sells $5,853 in common stock By Investing.com - Investing.com South Africa

May 19, 2026

Outset Medical: General counsel Brottem sells $9,760 in shares By Investing.com - Investing.com South Africa

May 19, 2026

Outset Medical CEO Leslie Trigg sells $12,746 in OM shares By Investing.com - Investing.com Nigeria

May 19, 2026

Outset Medical (OM) EVP sells 1,582 shares in tax-related ‘sell to cover’ - Stock Titan

May 19, 2026

May 18, 2026

BML Investment Partners takes 13.6% stake in Outset Medical (OM) - Stock Titan

May 18, 2026

Outset Medical (OM) major holder assigned 323K shares via June 2026 puts - Stock Titan

May 18, 2026

May 16, 2026

Outset Medical (OM) price target decreased by 14.81% to 7.82 - MSN

May 16, 2026

May 15, 2026

OM (NASDAQ: OM) settles 4,277 RSUs; Marc Nash sold 1,830 shares earlier - Stock Titan

May 15, 2026

OM (NASDAQ: OM) files Form 144 for 9,319 RSU settlement on 05/15/2026 - Stock Titan

May 15, 2026

OM (NASDAQ) director files Form 144 reporting 5,033 RSUs settled and prior sale - Stock Titan

May 15, 2026

Outset Medical (OM) amendment shows no beneficial ownership by Alyeska entities - Stock Titan

May 15, 2026

Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff - Insider Monkey

May 13, 2026

May 12, 2026

BML Investment Partners files 13G/A reporting 11.8% stake in Outset Medical (OM) - Stock Titan

May 12, 2026

Outset Medical (OM) 10% holder entities exercise derivatives to acquire over 294K shares - Stock Titan

May 12, 2026

May 11, 2026

Outset Medical to Present at RBC Global Healthcare Conference - The Manila Times

May 11, 2026

Dialysis tech firm Outset Medical to speak at RBC health conference - Stock Titan

May 11, 2026

Outset Medical net revenue drops 6% to USD 27.9M in Q1 2026 - Medical Buyer

May 11, 2026